CN117883121A - 利用呼出气诊断结核病和其他疾病 - Google Patents
利用呼出气诊断结核病和其他疾病 Download PDFInfo
- Publication number
- CN117883121A CN117883121A CN202311667384.8A CN202311667384A CN117883121A CN 117883121 A CN117883121 A CN 117883121A CN 202311667384 A CN202311667384 A CN 202311667384A CN 117883121 A CN117883121 A CN 117883121A
- Authority
- CN
- China
- Prior art keywords
- sample
- particles
- eba
- aerosol
- collecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000008827 tuberculosis Diseases 0.000 title abstract description 70
- 238000003745 diagnosis Methods 0.000 title abstract description 23
- 201000010099 disease Diseases 0.000 title abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 22
- 239000000443 aerosol Substances 0.000 claims abstract description 78
- 208000023504 respiratory system disease Diseases 0.000 claims abstract description 15
- 239000002245 particle Substances 0.000 claims description 118
- 239000003570 air Substances 0.000 claims description 78
- 238000000605 extraction Methods 0.000 claims description 47
- 239000012530 fluid Substances 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 32
- 230000000241 respiratory effect Effects 0.000 claims description 30
- 239000000090 biomarker Substances 0.000 claims description 28
- 150000002632 lipids Chemical class 0.000 claims description 12
- -1 cyanopropyl Chemical group 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 8
- 229920000936 Agarose Polymers 0.000 claims description 7
- 125000000524 functional group Chemical group 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- 229910000881 Cu alloy Inorganic materials 0.000 claims description 6
- 239000012080 ambient air Substances 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- YOCUPQPZWBBYIX-UHFFFAOYSA-N copper nickel Chemical compound [Ni].[Cu] YOCUPQPZWBBYIX-UHFFFAOYSA-N 0.000 claims description 5
- 239000002105 nanoparticle Substances 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- OANFWJQPUHQWDL-UHFFFAOYSA-N copper iron manganese nickel Chemical compound [Mn].[Fe].[Ni].[Cu] OANFWJQPUHQWDL-UHFFFAOYSA-N 0.000 claims description 4
- 230000001186 cumulative effect Effects 0.000 claims description 4
- 238000005342 ion exchange Methods 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 230000002572 peristaltic effect Effects 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 229920005654 Sephadex Polymers 0.000 claims description 3
- 239000012507 Sephadex™ Substances 0.000 claims description 3
- 229920002684 Sepharose Polymers 0.000 claims description 3
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N divinylbenzene Substances C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 230000002503 metabolic effect Effects 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 59
- 238000003556 assay Methods 0.000 abstract description 17
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 abstract description 12
- 238000004949 mass spectrometry Methods 0.000 abstract description 10
- 238000002405 diagnostic procedure Methods 0.000 abstract description 8
- 239000000523 sample Substances 0.000 description 194
- 238000004458 analytical method Methods 0.000 description 39
- 206010011224 Cough Diseases 0.000 description 24
- 238000012360 testing method Methods 0.000 description 20
- 238000012545 processing Methods 0.000 description 19
- 206010036790 Productive cough Diseases 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 18
- 208000024794 sputum Diseases 0.000 description 18
- 210000003802 sputum Anatomy 0.000 description 18
- 208000015181 infectious disease Diseases 0.000 description 17
- 238000001816 cooling Methods 0.000 description 16
- 239000011159 matrix material Substances 0.000 description 16
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 16
- 238000005070 sampling Methods 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000009471 action Effects 0.000 description 13
- 230000029058 respiratory gaseous exchange Effects 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 210000002345 respiratory system Anatomy 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 210000003800 pharynx Anatomy 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- 206010022000 influenza Diseases 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000513 principal component analysis Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000012468 concentrated sample Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002023 wood Substances 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000006199 nebulizer Substances 0.000 description 4
- 239000012508 resin bead Substances 0.000 description 4
- 206010041232 sneezing Diseases 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000012855 volatile organic compound Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical class C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 208000019693 Lung disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 208000036981 active tuberculosis Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000132 electrospray ionisation Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 230000005679 Peltier effect Effects 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 238000004159 blood analysis Methods 0.000 description 2
- 210000003123 bronchiole Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013123 lung function test Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical class C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000028571 Occupational disease Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 229920000690 Tyvek Polymers 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- 208000024716 acute asthma Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 244000000022 airborne pathogen Species 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical group OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- MRPWWVMHWSDJEH-UHFFFAOYSA-N antimony telluride Chemical compound [SbH3+3].[SbH3+3].[TeH2-2].[TeH2-2].[TeH2-2] MRPWWVMHWSDJEH-UHFFFAOYSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000000491 multivariate analysis Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical class C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- OMEPJWROJCQMMU-UHFFFAOYSA-N selanylidenebismuth;selenium Chemical compound [Se].[Bi]=[Se].[Bi]=[Se] OMEPJWROJCQMMU-UHFFFAOYSA-N 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- XSOKHXFFCGXDJZ-UHFFFAOYSA-N telluride(2-) Chemical compound [Te-2] XSOKHXFFCGXDJZ-UHFFFAOYSA-N 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7206—Mass spectrometers interfaced to gas chromatograph
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0833—Measuring rate of oxygen consumption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0836—Measuring rate of CO2 production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/091—Measuring volume of inspired or expired gases, e.g. to determine lung capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/097—Devices for facilitating collection of breath or for directing breath into or through measuring devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/22—Devices for withdrawing samples in the gaseous state
- G01N1/2202—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling
- G01N1/2205—Devices for withdrawing samples in the gaseous state involving separation of sample components during sampling with filters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B2010/0083—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements for taking gas samples
- A61B2010/0087—Breath samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/029—Humidity sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/025—Gas chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891954P | 2019-08-26 | 2019-08-26 | |
| US62/891,954 | 2019-08-26 | ||
| US202063069120P | 2020-08-23 | 2020-08-23 | |
| US63/069,120 | 2020-08-23 | ||
| PCT/US2020/048040 WO2021041571A1 (en) | 2019-08-26 | 2020-08-26 | Diagnosis of tuberculosis and other diseases using exhaled breath |
| CN202080067765.0A CN114449957B (zh) | 2019-08-26 | 2020-08-26 | 利用呼出气诊断结核病和其他疾病 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080067765.0A Division CN114449957B (zh) | 2019-08-26 | 2020-08-26 | 利用呼出气诊断结核病和其他疾病 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117883121A true CN117883121A (zh) | 2024-04-16 |
Family
ID=74685243
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311667384.8A Pending CN117883121A (zh) | 2019-08-26 | 2020-08-26 | 利用呼出气诊断结核病和其他疾病 |
| CN202080067765.0A Active CN114449957B (zh) | 2019-08-26 | 2020-08-26 | 利用呼出气诊断结核病和其他疾病 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080067765.0A Active CN114449957B (zh) | 2019-08-26 | 2020-08-26 | 利用呼出气诊断结核病和其他疾病 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20220322963A1 (https=) |
| EP (1) | EP4021294A4 (https=) |
| JP (2) | JP7411281B2 (https=) |
| KR (2) | KR102543496B1 (https=) |
| CN (2) | CN117883121A (https=) |
| WO (1) | WO2021041571A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117883121A (zh) | 2019-08-26 | 2024-04-16 | 泽特奥科技公司 | 利用呼出气诊断结核病和其他疾病 |
| CN114585903B (zh) | 2019-09-23 | 2023-08-04 | 泽特奥科技公司 | 快速自主检测气溶胶粒子的系统和方法 |
| US12074018B2 (en) | 2019-09-23 | 2024-08-27 | Zeteo Tech, Inc. | Systems and methods of rapid and autonomous detection of aerosol particles |
| US12442726B2 (en) | 2020-04-19 | 2025-10-14 | John J. Daniels | Mask-based testing system for detecting biomarkers in exhaled breath condensate, aerosols and gases |
| US12369816B2 (en) | 2020-04-19 | 2025-07-29 | John J. Daniels | Mask-based diagnostic system using exhaled breath condensate |
| US12533047B2 (en) | 2020-04-19 | 2026-01-27 | John J. Daniels | Mask-based diagnostic system using exhaled breath condensate |
| US12031982B2 (en) * | 2020-04-19 | 2024-07-09 | John J. Daniels | Using exhaled breath condensate for testing for a biomarker of COVID-19 |
| CN115715417A (zh) * | 2020-06-17 | 2023-02-24 | 里沃恩株式会社 | 系统、信息处理装置及程序 |
| US20220155280A1 (en) * | 2020-11-16 | 2022-05-19 | Koninklijke Fabriek Inventum B.V. | Systems and methods for collecting a biological sample from a passenger cabin |
| KR102652313B1 (ko) * | 2021-03-05 | 2024-03-29 | 재단법인 아산사회복지재단 | 호기 응축물 시료를 이용한 세균 메타게놈 분석 방법 |
| US20220386893A1 (en) * | 2021-03-31 | 2022-12-08 | Zeteo Tech Inc. | Capturing truncated proteoforms in exhaled breath for diagnosis and treatment of diseases |
| EP4312749A4 (en) * | 2021-03-31 | 2025-07-09 | Zeteo Tech Inc | DIAGNOSIS OF RESPIRATORY DISEASES BY CAPTURE OF AEROSOLIZED BIOMATERIAL PARTICLES USING FIXED BED SYSTEMS AND METHODS |
| ES2906212B2 (es) * | 2021-04-22 | 2023-06-22 | Univ Valencia Politecnica | Biosensor y virusometro de deteccion de patogenos en aire y en muestras liquidas |
| WO2022248936A2 (en) * | 2021-05-28 | 2022-12-01 | Exhalation Technology Ltd | Device and method for detecting a component of exhaled breath condensate |
| GB202110582D0 (en) * | 2021-07-22 | 2021-09-08 | Owlstone Med Ltd | Breath sampling device |
| US11897495B2 (en) | 2021-08-05 | 2024-02-13 | Hyundai Mobis Co., Ltd. | Drunk driving prevention system and method therefor |
| KR20250067957A (ko) * | 2021-10-12 | 2025-05-15 | 제테오 테크, 인코포레이티드 | 호기 호흡을 이용한 결핵 및 기타 질병의 진단 |
| US20240423497A1 (en) * | 2021-11-02 | 2024-12-26 | Pexa Ab | A device and method for determining a respiratory system infection from exhaled breath |
| WO2023086823A1 (en) * | 2021-11-09 | 2023-05-19 | Quintron Instrument Company, Inc. | Apparatus and methods for viral and bacterial breath collection |
| CN114533037B (zh) * | 2022-02-23 | 2022-11-22 | 安徽省立医院(中国科学技术大学附属第一医院) | 一种基于儿童呼吸气体的疾病检测系统及方法 |
| SE547329C2 (en) * | 2022-06-03 | 2025-07-01 | Munkplast Ab | Method and system for preparing a breath sample for analysis |
| JP2025528164A (ja) * | 2022-08-11 | 2025-08-26 | ゼテオ テック、 インク． | 疾患の診断および治療のための呼気中の切断プロテオフォームの捕捉 |
| CN115350556A (zh) * | 2022-08-16 | 2022-11-18 | 苏州思萃同位素技术研究所有限公司 | Co2呼气试验中呼出co2的处置及回收方法和装置 |
| CN115326972A (zh) * | 2022-08-18 | 2022-11-11 | 浙江大学 | 冷凝收集非侵入式测定人体呼出气中糖类的分析装置及方法 |
| CN115326986A (zh) * | 2022-08-29 | 2022-11-11 | 浙江大学 | 一种测定人体呼出气中有机酸和阴离子的分析装置及方法 |
| US20240264145A1 (en) * | 2023-02-07 | 2024-08-08 | Aleck Alexopoulos | Device, method, and system for the rapid detection of the tuberculosis mycobacterium dispersed in air |
| US20250366717A1 (en) * | 2024-05-31 | 2025-12-04 | David Michaeli | Non-contact rapid diagnosis of illness by laser, infra red, terahertz and/or uv spectroscopy and analysis of water mixture envelope |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5848608U (ja) | 1981-09-24 | 1983-04-01 | 極東開発工業株式会社 | 塵芥圧縮押込装置 |
| JPH09126958A (ja) * | 1995-10-30 | 1997-05-16 | Suzuki Motor Corp | 呼気採取装置 |
| JPH10227725A (ja) * | 1997-02-12 | 1998-08-25 | Suzuki Motor Corp | 呼気分析装置 |
| US6062392A (en) | 1998-11-13 | 2000-05-16 | Mesosystems Technology, Inc. | Micromachined virtual impactor |
| US6267016B1 (en) | 1999-03-10 | 2001-07-31 | Mesosystems Technology, Inc. | Impact particulate collector using a rotary impeller for collecting particulates and moving a fluid |
| JP2001318069A (ja) * | 2000-05-10 | 2001-11-16 | Matsushita Electric Ind Co Ltd | 呼気ガス分析装置 |
| US7118537B2 (en) * | 2001-04-30 | 2006-10-10 | Respiratory Research, Inc. | Method and device for collecting and analyzing exhaled breath |
| US7364553B2 (en) * | 2002-12-20 | 2008-04-29 | Amidex, Inc. | Breath aerosol management and collection system |
| US20050085740A1 (en) * | 2003-04-01 | 2005-04-21 | Davis Cristina E. | Non-invasive breath analysis using field asymmetric ion mobility spectrometry |
| AU2004294342A1 (en) * | 2003-12-01 | 2005-06-16 | Sierra Medical Technology, Inc. | A respiratory monitoring, diagnostic and therapeutic system |
| MXPA06014248A (es) * | 2004-06-07 | 2007-06-25 | Charlotte Mecklenburg Hospital | Uso de lipopoliscarido en condensado de respiracion exhalada para diagnosticar neumonia gram negativa. |
| US8627821B2 (en) * | 2005-01-10 | 2014-01-14 | Pulmatrix, Inc. | Method and device for decreasing contamination |
| JP4564406B2 (ja) | 2005-05-25 | 2010-10-20 | 株式会社日立製作所 | 呼気捕集フィルタ、呼気収集装置、呼気分析システムおよび呼気分析方法 |
| US7779840B2 (en) * | 2006-06-21 | 2010-08-24 | General Electric Company | Ventilator breath condensate sampler and method of collecting a breath condensate sample |
| CA2701352A1 (en) * | 2007-10-02 | 2009-04-09 | Ann-Charlotte Almstrand | Collection and measurement of exhaled particles |
| EP2060919A1 (en) | 2007-11-13 | 2009-05-20 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | MALDI matrix and MALDI method |
| JP5289837B2 (ja) * | 2008-06-30 | 2013-09-11 | 日本光電工業株式会社 | 生体由来ガス成分分析装置及び疾病判定支援装置 |
| JP5848608B2 (ja) * | 2008-12-01 | 2016-01-27 | トリコーンテク コーポレーションＴｒｉｃｏｒｎＴｅｃｈ Ｃｏｒｐｏｒａｔｉｏｎ | 喘息、結核及び肺癌の診断及び疾患管理のための呼気分析システム及び方法 |
| EA023922B1 (ru) | 2009-09-09 | 2016-07-29 | Сенса Буэс Аб | Обнаружение лекарственного средства в выдыхаемом воздухе |
| US9417232B2 (en) | 2009-10-02 | 2016-08-16 | Bi Mobile Breath, Inc. | Sobriety monitoring system |
| EP2591331A4 (en) * | 2010-07-06 | 2017-06-07 | Deton Corp. | System for airborne bacterial sample collection and analysis |
| US8747325B2 (en) | 2010-07-16 | 2014-06-10 | Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo (Fapesp) | Non-invasive method for diagnosing the severity of heart failure by extracting and analyzing acetone concentrations in captured exhaled breath |
| US20120172677A1 (en) * | 2010-12-30 | 2012-07-05 | Logan Robert J | Systems and methods for monitoring and processing biometric data |
| US11547322B2 (en) * | 2012-02-08 | 2023-01-10 | Lundin Stefan | Device and method for non-invasive analysis of particles during medical ventilation |
| EP3667317A1 (en) | 2012-03-08 | 2020-06-17 | Sensa Bues AB | A portable sampling device and method for detection of biomarkers in exhaled breath |
| US9164080B2 (en) * | 2012-06-11 | 2015-10-20 | Ohio State Innovation Foundation | System and method for sensing NO |
| JP2016512431A (ja) * | 2013-03-12 | 2016-04-28 | デトン コーポレイション | 呼吸サンプルの収集および分析のためのシステム |
| US10307080B2 (en) * | 2014-03-07 | 2019-06-04 | Spirosure, Inc. | Respiratory monitor |
| ES2734380T3 (es) | 2014-06-27 | 2019-12-05 | Pulse Health Llc | Cartucho de análisis y método de uso del mismo |
| KR20160009740A (ko) * | 2014-07-16 | 2016-01-27 | 연세대학교 산학협력단 | 말디톱 질량분석기에 이용가능한 시료 플레이트 및 상기 시료 플레이트의 제조방법, 그리고 상기 시료 플레이트를 이용한 질량분석 방법 |
| US10598668B2 (en) | 2015-08-24 | 2020-03-24 | Zeteo Tech, Inc. | Coating of aerosol particles using an acoustic coater |
| EP3349710B1 (en) * | 2015-09-15 | 2025-07-02 | Koninklijke Philips N.V. | Neonatal incubator |
| EP3143930A1 (en) * | 2015-09-21 | 2017-03-22 | Université de Liège | Method for the diagnosis of airway disease inflammatory subtype |
| US10226201B2 (en) * | 2015-10-29 | 2019-03-12 | Invoy Holdings, Llc | Flow regulation device for breath analysis and related method |
| US11116422B2 (en) * | 2015-12-21 | 2021-09-14 | Koninklijke Philips N.V. | Sample cells for respired gas sampling and methods of manufacturing same |
| KR20180137516A (ko) | 2016-04-15 | 2018-12-27 | 예일 유니버시티 | 기체 환경에서 유기 화합물을 모니터링하기 위한 시스템, 기기 및 방법 |
| US10502665B2 (en) * | 2016-04-18 | 2019-12-10 | University Of Maryland, College Park | Aerosol collection system and method |
| CN109310368A (zh) | 2016-04-25 | 2019-02-05 | 奥斯通医疗有限公司 | 用于捕获呼吸样本的系统和设备 |
| US10960002B2 (en) * | 2016-05-13 | 2021-03-30 | The Brigham And Women's Hospital, Inc. | Volatile metabolite profiles for the diagnosis and treatment of Mucorales fungi |
| AU2017353360B2 (en) * | 2016-11-07 | 2023-01-19 | AusMed Global Limited | Non-invasive photonic sensing for monitoring diabetes |
| MX2020010523A (es) * | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| GB201704367D0 (en) | 2017-03-20 | 2017-05-03 | Exhalation Tech Ltd | A breath condensate analyser |
| JP6967198B2 (ja) | 2017-05-18 | 2021-11-17 | 東海光学株式会社 | 呼気ミスト捕集装置、呼気ミスト分析システム、呼気ミスト捕集方法及び呼気ミスト分析方法 |
| SE541748C2 (en) * | 2017-07-10 | 2019-12-10 | Pexa Ab | System for collecting exhaled particles |
| GB201801153D0 (en) * | 2018-01-24 | 2018-03-07 | Owlstone Med Ltd | Apparatus and method for obtaining a breath sample |
| US20200147333A1 (en) * | 2018-11-09 | 2020-05-14 | Hound Labs, Inc. | Breath sample systems for use with ventilators |
| US11678829B2 (en) | 2019-04-17 | 2023-06-20 | Masimo Corporation | Physiological monitoring device attachment assembly |
| WO2021061247A2 (en) | 2019-06-29 | 2021-04-01 | Zeteo Tech, Inc. | Methods and systems for detecting aerosol particles without using complex organic maldi matrices |
| CN117883121A (zh) | 2019-08-26 | 2024-04-16 | 泽特奥科技公司 | 利用呼出气诊断结核病和其他疾病 |
| CN114585903B (zh) | 2019-09-23 | 2023-08-04 | 泽特奥科技公司 | 快速自主检测气溶胶粒子的系统和方法 |
| KR102630689B1 (ko) | 2020-04-03 | 2024-01-29 | 제테오 테크, 인코포레이티드 | 호기 및 에어로졸 분석을 이용한 호흡기 질환 진단 |
| US12364411B2 (en) * | 2020-04-03 | 2025-07-22 | Zeteo Tech, Inc. | Diagnosis of respiratory diseases using analysis of exhaled breath and aerosols |
| US20210318208A1 (en) | 2020-04-09 | 2021-10-14 | Hygieia Sciences LLC | Method of Detection of Diseases Related to Coronavirus Infection by Breath Analysis |
| US12533047B2 (en) * | 2020-04-19 | 2026-01-27 | John J. Daniels | Mask-based diagnostic system using exhaled breath condensate |
| US20240074673A1 (en) * | 2021-03-31 | 2024-03-07 | Zeteo Tech, Inc. | Capturing truncated proteoforms in exhaled breath for diagnosis of tuberculosis |
| US20220386893A1 (en) * | 2021-03-31 | 2022-12-08 | Zeteo Tech Inc. | Capturing truncated proteoforms in exhaled breath for diagnosis and treatment of diseases |
| EP4312749A4 (en) * | 2021-03-31 | 2025-07-09 | Zeteo Tech Inc | DIAGNOSIS OF RESPIRATORY DISEASES BY CAPTURE OF AEROSOLIZED BIOMATERIAL PARTICLES USING FIXED BED SYSTEMS AND METHODS |
| SE546321C2 (en) | 2021-04-08 | 2024-10-01 | Pinsalus Ab | System for breath analysis comprising a breath sampling apparatus and a sample preparation apparatus |
| WO2022251882A1 (en) | 2021-05-28 | 2022-12-01 | Entech Instruments Inc. | System and method of gas sampling for trace-level analysis of chemical compounds |
-
2020
- 2020-08-26 CN CN202311667384.8A patent/CN117883121A/zh active Pending
- 2020-08-26 WO PCT/US2020/048040 patent/WO2021041571A1/en not_active Ceased
- 2020-08-26 KR KR1020227045514A patent/KR102543496B1/ko active Active
- 2020-08-26 JP JP2022512715A patent/JP7411281B2/ja active Active
- 2020-08-26 CN CN202080067765.0A patent/CN114449957B/zh active Active
- 2020-08-26 US US17/638,800 patent/US20220322963A1/en not_active Abandoned
- 2020-08-26 EP EP20857633.0A patent/EP4021294A4/en active Pending
- 2020-08-26 KR KR1020227008057A patent/KR102485642B1/ko active Active
-
2021
- 2021-10-12 US US17/499,848 patent/US12019056B2/en active Active
-
2023
- 2023-12-18 JP JP2023212642A patent/JP7640129B2/ja active Active
-
2024
- 2024-06-25 US US18/753,980 patent/US12467910B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022545289A (ja) | 2022-10-26 |
| KR20220047317A (ko) | 2022-04-15 |
| JP7411281B2 (ja) | 2024-01-11 |
| US20240345042A1 (en) | 2024-10-17 |
| KR102485642B1 (ko) | 2023-01-06 |
| JP7640129B2 (ja) | 2025-03-05 |
| US12019056B2 (en) | 2024-06-25 |
| KR102543496B1 (ko) | 2023-06-13 |
| US20220322963A1 (en) | 2022-10-13 |
| US12467910B2 (en) | 2025-11-11 |
| KR20230003457A (ko) | 2023-01-05 |
| CN114449957A (zh) | 2022-05-06 |
| US20220034854A1 (en) | 2022-02-03 |
| WO2021041571A1 (en) | 2021-03-04 |
| JP2024029004A (ja) | 2024-03-05 |
| CN114449957B (zh) | 2023-11-24 |
| EP4021294A4 (en) | 2023-07-12 |
| EP4021294A1 (en) | 2022-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114449957B (zh) | 利用呼出气诊断结核病和其他疾病 | |
| JP7504499B2 (ja) | 呼気およびエアロゾルの分析を用いた呼吸器疾患の診断 | |
| KR102790377B1 (ko) | 인공호흡기를 이용하여 호흡하는 환자를 모니터링하기위한 호기 수집 시스템 및 방법 | |
| CN101827558B (zh) | 呼出的粒子的采集和测量 | |
| JP2022545289A5 (https=) | ||
| US12364411B2 (en) | Diagnosis of respiratory diseases using analysis of exhaled breath and aerosols | |
| KR102804601B1 (ko) | 호기 호흡을 이용한 결핵 및 기타 질병의 진단 | |
| US20260060567A1 (en) | Systems and methods for capturing aerosolized biomaterial particles using packed beds | |
| WO2024249186A1 (en) | Systems and methods for capturing aerosolized biomaterial particles using packed beds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |